Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software platforms and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Sixth Consecutive Year

Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software platforms and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Certara Partners with Galderma to Attain FDA Approval of AKLIEF® Topical Acne Cream

Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software platforms and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Certara’s Best of the Blog 2019

Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software platforms and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Certara’s Kevin Trimm cited in Scientific Computing World article on CDISC Data Standards

Learn More With Certara

Focused on accelerating the pace of innovation in our field, Certara’s scientists and regulatory experts share learnings, technological advances, and thought leadership.

Leveraging Public Data for Strategic Drug Development More Common Myths about PBPK for Drug Development Busted! More A Guide to Successful Market Access More Best Practices for Developing Investigational Drug Submissions More

最新情報

Blog

In the Press

Webinars

Events